Latest news
Loading news…
Alnylam Pharmaceuticals
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Cambridge, Massachusetts, United States Founded 2002 1001-5000 employees For Profit
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Monthly Visits
Available in Pro Contacts
2,164
Ticker
ALNY
NASDAQ
Patents
857
99 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- ALNY
- Exchange
- NASDAQ
- IPO date
- Mar 4, 2022
- Raised at IPO
- $30M
- Valuation at IPO
- $114M
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 91
- Active products
- 33
- Patents granted
- 857
- Trademarks
- 99
- Top patent class
- Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering
- IT spend
- $81M
Company Info
- Founded
- 2002
- Employees
- 1001-5000
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 8
- News articles
- 1,044
- HQ
- Cambridge, Massachusetts, United States
- Region
- Greater Boston Area, East Coast, New England
- Exit date
- Mar 4, 2022
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- 2.1
- Trend (30d)
- -0.4
- Trend (90d)
- -0.1
- Last leadership hire
- Dec 2, 2025
- Last layoff mention
- Mar 30, 2026
Acquisitions by Alnylam Pharmaceuticals
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Alnylam Pharmaceuticals
President
Chief Financial Officer
Member of Scientific Advisory Board
Senior Vice President, Chief Patent Counsel
Scientific Advisory Board
Chief Diversity, Equity and Inclusion Officer
Senior Vice President CMC Development
Executive Vice President & Chief Legal Officer
Senior Vice President
Scientific Advisory Board and Founder
Senior Vice President, Innovation Chemistry & Alnylam Distinguished Scientist
Global Digital Media Buying and Operations
Senior Director, Digital Engagement Global Commercial Team
Quality Assurance
Vice President, Human Resources
Global Head of Transformational (Emerging) Technologies
Director, CNS Early Development
Chief Executive Officer
Director & Global Medical Affairs
Member of Scientific Advisory Board
Executive Vice President and Chief Research and Development Officer
Director, Process Chemistry
Executive Director of Clinical Research
Associate Director
2,164
professional contacts at Alnylam Pharmaceuticals
Contact execs at Alnylam Pharmaceuticals →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Alnylam Pharmaceuticals
Loading news…
FAQs about Alnylam Pharmaceuticals
People who checked this page also checked these
Sectors Alnylam Pharmaceuticals invests & acquires in
Browse the full Acquirezy directory.